TABLE 1

Patient characteristics

All patientsPCR positivePCR negativep-value
Subjects n187#86100
Age years63.7±15.763.4±14.864.1±16.50.668
Male108 (57.8)50 (58.1)58 (58.0)0.97
Admission140 (74.9)65 (75.6)75 (75.0)0.855
Admission ED to IC9 (4.8)8 (9.3)1 (1.0)<0.001
In hospital mortality9 (4.8)5 (5.8)4 (4.0)0.001
Obesity (based on clinical assessment)52 (27.8)27 (31.4)25 (25)0.676
Duration of symptoms days6.5±5.17.3±4.15.8±5.80.007
Comorbidities
 Asthma10 (5.3)3 (3.5)7 (7.0)0.033
 Chronic cardiovascular disease44 (23.5)18 (20.9)26 (26.0)0.104
 COPD (GOLD stage >2)30 (5.3)12 (14.0)18 (18.0)0.134
 Current malignancy35 (18.7)9 (10.5)26 (26.0)<0.001
 Diabetes mellitus36 (19.3)21 (24.4)15 (15.0)0.001
Laboratory analysis on admission
 CRP mg·L−1 median (interquartile range)59 (81.5)68 (83.8)49.0 (80.8)0.73
 Procalcitonin ng·mL−1 median (interquartile range)0.1 (0.25)0.12 (0.21)0.1 (0.37)0.004
 Positive blood culture12 (6.4)1 (1.2)11 (11.0)0.204
 Positive influenza A/B0000.593
Observations
 Modified early warning score (MEWS)2.6±1.82.9±1.62.3±1.80.605
 Temperature °C37.5±1.237.8±1.137.2±1.30.174
 Respiratory rate min-121.2±6.921.9±7.220.7±6.70.888
 Oxygen saturation %95.8±3.294.9(3.596.4±2.80.165
 Oxygen therapy58 (0.31)34 (39.5)24 (24.0)0.004
 Intubation9 (4.8)8 (9.3)1 (1.0)<0.001

Data are presented as mean±sd or n (%), unless otherwise stated. Statistically significant differences between the PCR positive and PCR negative groups are emphasised in bold text. ED: emergency department; IC: intensive care; GOLD: Global Initiative for Chronic Obstructive Lung Disease; CRP: C-reactive protein. #: One patient had an indeterminate PCR and no repeat PCR, therefore the total amount of patients (187) differs from the sum of the PCR positives (86) and PCR negatives (100).